Vikram Malik, MD
Internal Medicine · Warwick, RINPI 1205356326
Payments from drug & device makers
Across 513 payments — averaging $24.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$2K
- Regeneron Healthcare Solutions, Inc.$2K
- Sanofi$1K
- Biocryst US Sales Co., LLC$832
- CSL Behring$598
- plus $4K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 92 | $2,421 |
| GSK | 107 | $2,017 |
| Regeneron Healthcare Solutions, Inc. | 63 | $1,647 |
| Sanofi | 26 | $1,028 |
| Biocryst US Sales Co., LLC | 19 | $832 |
| CSL Behring | 22 | $598 |
| Novartis | 48 | $560 |
| Amgen(2 entities) | 23 | $429 |
| Pharming Healthcare, Inc. | 14 | $342 |
| Optinose US, Inc. | 12 | $281 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $263 |
| Grifols USA, LLC | 10 | $227 |
| Kaleo, Inc. | 11 | $204 |
| Alk-abello, Inc | 5 | $192 |
| Dermavant Sciences, Inc. | 2 | $175 |
| Pfizer | 7 | $131 |
| AbbVie | 5 | $125 |
| Biohaven Pharmaceuticals, Inc. | 1 | $125 |
| Boehringer Ingelheim | 5 | $119 |
| Blueprint Medicines Corporation | 4 | $114 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $104 |
| Hikma Pharmaceuticals USA | 5 | $88 |
| Arcutis Biotherapeutics, Inc. | 2 | $54 |
| Verona Pharma, Inc. | 2 | $53 |
| Organon | 2 | $50 |
| LEO Pharma Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Sanofi-aventis U.S. LLC | 1 | $28 |
| Paratek Pharmaceuticals, Inc. | 1 | $27 |
| Genentech USA, Inc. | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| Greer Laboratories, Inc. | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Incyte Corporation | 1 | $19 |
| Merck | 1 | $18 |
How this compares
$12,449 in reported general payments places this provider in the 95th percentile of 808 internal medicine providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Warwick
- Munawar AzamWarwick$8K
- David FriedEast Greenwich$37.2M
- Gregory AllenCranston$12.2M
- Kathleen GordonJohnston$1.1M
- William BeliveauJohnson$962K
- Scott WilsonCumberland$907K
- Aaron SamuelsProvidence$751K
- Frank D'alessandroLincoln$541K
- Andrew HsuProvidence$409K
- Heinrich ElinzanoProvidence$396K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.